This strategy enables Pfizer to maintain a strong foothold in the generic drug market while also protecting its revenue ...

South Korean pharmaceutical and biotechnology companies are on edge as U.S. President Donald Trump signals the introduction ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Biosimilars Market Poised for Rapid Growth, Driven by Advancements in Therapeutics and Expanding Patient AccessPune, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Global Biosimilars Market Size & Growth Analysis: ...